These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 33910869)

  • 41. Impact of 18F-FDG PET/CT in the treatment of patients with non-small cell lung cancer.
    Taus Á; Aguiló R; Curull V; Suárez-Piñera M; Rodríguez-Fuster A; Rodríguez de Dios N; Pijuan L; Zuccarino F; Vollmer I; Sánchez-Font A; Belda-Sanchis J; Arriola E
    Arch Bronconeumol; 2014 Mar; 50(3):99-104. PubMed ID: 24360985
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diagnostic accuracy of 18F-2-deoxy-fluoro-D-glucose positron emission tomography for pN1 lymph nodes in patients with lung cancer.
    Nakagawa M; Hara M; Sakurai K; Ozawa Y; Mizuno A; Tamaki T; Nishio M; Shibamoto Y
    Acta Radiol; 2009 Jul; 50(6):638-44. PubMed ID: 19492198
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prediction of mediastinal lymph node metastasis based on
    Yin G; Song Y; Li X; Zhu L; Su Q; Dai D; Xu W
    Eur Radiol; 2021 Jun; 31(6):3983-3992. PubMed ID: 33201286
    [TBL] [Abstract][Full Text] [Related]  

  • 44. FDG-PET/CT for pretherapeutic lymph node staging in non-small cell lung cancer: A tailored approach to the ESTS/ESMO guideline workflow.
    Rogasch JMM; Frost N; Bluemel S; Michaels L; Penzkofer T; von Laffert M; Temmesfeld-Wollbrück B; Neudecker J; Rückert JC; Ochsenreither S; Böhmer D; Amthauer H; Furth C
    Lung Cancer; 2021 Jul; 157():66-74. PubMed ID: 33994197
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis.
    Gould MK; Kuschner WG; Rydzak CE; Maclean CC; Demas AN; Shigemitsu H; Chan JK; Owens DK
    Ann Intern Med; 2003 Dec; 139(11):879-92. PubMed ID: 14644890
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Occult nodal metastasis in patients with non-small cell lung cancer at clinical stage IA by PET/CT.
    Park HK; Jeon K; Koh WJ; Suh GY; Kim H; Kwon OJ; Chung MP; Lee KS; Shim YM; Han J; Um SW
    Respirology; 2010 Nov; 15(8):1179-84. PubMed ID: 20573058
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diagnosis of the presence of lymph node metastasis and decision of operative indication using fluorodeoxyglucose-positron emission tomography and computed tomography in patients with primary lung cancer.
    Toba H; Kondo K; Otsuka H; Takizawa H; Kenzaki K; Sakiyama S; Tangoku A
    J Med Invest; 2010 Aug; 57(3-4):305-13. PubMed ID: 20847531
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lymph node staging in non-small cell lung cancer: evaluation by [18F]FDG positron emission tomography (PET).
    Guhlmann A; Storck M; Kotzerke J; Moog F; Sunder-Plassmann L; Reske SN
    Thorax; 1997 May; 52(5):438-41. PubMed ID: 9176535
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tumor-to-liver standard uptake ratio using fluorine-18 fluorodeoxyglucose positron emission tomography computed tomography effectively predict occult lymph node metastasis of non-small cell lung cancer patients.
    Shi YM; Niu R; Shao XL; Zhang FF; Shao XN; Wang JF; Wang XS; Liu B; Yu WJ; Wang YT
    Nucl Med Commun; 2020 May; 41(5):459-468. PubMed ID: 32187163
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical utility of [
    Zhang L; E H; Huang J; Wu J; Li Q; Hou L; Li C; Dai C; Deng J; Yang M; Ma M; Ren Y; Luo Q; Zhao D; Chen C
    Eur Radiol; 2023 Dec; 33(12):8564-8572. PubMed ID: 37464112
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Implications of false negative and false positive diagnosis in lymph node staging of NSCLC by means of ¹⁸F-FDG PET/CT.
    Li S; Zheng Q; Ma Y; Wang Y; Feng Y; Zhao B; Yang Y
    PLoS One; 2013; 8(10):e78552. PubMed ID: 24205256
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinico-biological-radiomics (CBR) based machine learning for improving the diagnostic accuracy of FDG-PET false-positive lymph nodes in lung cancer.
    Ren C; Zhang F; Zhang J; Song S; Sun Y; Cheng J
    Eur J Med Res; 2023 Dec; 28(1):554. PubMed ID: 38042812
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mediastinal staging in Non-Small-Cell Lung Carcinoma: computed tomography versus F-18-fluorodeoxyglucose positron-emission tomography and computed tomography.
    Harders SW; Madsen HH; Hjorthaug K; Arveschoug AK; Rasmussen TR; Meldgaard P; Hoejbjerg JA; Pilegaard HK; Hager H; Rehling M; Rasmussen F
    Cancer Imaging; 2014 Jun; 14(1):23. PubMed ID: 25608616
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Accuracy of nodal staging by 18F-FDG-PET/CT in limited disease small-cell lung cancer.
    Hockmann J; Hautzel H; Darwiche K; Eberhard W; Stuschke M; Aigner C; Herrmann K; Plönes T
    Asian Cardiovasc Thorac Ann; 2023 Jul; 31(6):506-511. PubMed ID: 37438928
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mediastinal lymph node staging with FDG-PET scan in patients with potentially operable non-small cell lung cancer: a prospective analysis of 50 cases. Leuven Lung Cancer Group.
    Vansteenkiste JF; Stroobants SG; De Leyn PR; Dupont PJ; Verschakelen JA; Nackaerts KL; Mortelmans LA
    Chest; 1997 Dec; 112(6):1480-6. PubMed ID: 9404742
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PET-CT in presurgical lymph node staging in non-small cell lung cancer: the importance of false-negative and false-positive findings.
    Bustos García de Castro A; Ferreirós Domínguez J; Delgado Bolton R; Fernández Pérez C; Cabeza Martínez B; García García-Esquinas M; Carreras Delgado JL
    Radiologia; 2017; 59(2):147-158. PubMed ID: 28238444
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ratio of the maximum standardized uptake value on FDG-PET of the mediastinal (N2) lymph nodes to the primary tumor may be a universal predictor of nodal malignancy in patients with nonsmall-cell lung cancer.
    Cerfolio RJ; Bryant AS
    Ann Thorac Surg; 2007 May; 83(5):1826-9; discussion 1829-30. PubMed ID: 17462407
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Endobronchial ultrasound-guided transbronchial needle aspiration for systematic nodal staging of lung cancer in patients with N0 disease by computed tomography and integrated positron emission tomography-computed tomography.
    Ong P; Grosu H; Eapen GA; Rodriguez M; Lazarus D; Ost D; Jimenez CA; Morice R; Bandi V; Tamara L; Cornwell L; Green L; Zhu A; Casal RF
    Ann Am Thorac Soc; 2015 Mar; 12(3):415-9. PubMed ID: 25584815
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dexamethasone Suppression FDG PET/CT for Differentiating between True- and False-Positive Pulmonary and Mediastinal Lymph Node Metastases in Non-Small Cell Lung Cancer: A Pilot Study of FDG PET/CT after Oral Administration of Dexamethasone.
    Nakajo M; Nakajo M; Nakayama H; Jinguji M; Nakabeppu Y; Higashi M; Nakamura Y; Sato M; Yoshiura T
    Radiology; 2016 Apr; 279(1):246-53. PubMed ID: 26579562
    [TBL] [Abstract][Full Text] [Related]  

  • 60. DaPeCa-3: promising results of sentinel node biopsy combined with (18) F-fluorodeoxyglucose positron emission tomography/computed tomography in clinically lymph node-negative patients with penile cancer - a national study from Denmark.
    Jakobsen JK; Alslev L; Ipsen P; Costa JC; Krarup KP; Sommer P; Nerstrøm H; Toft BG; Høyer S; Bouchelouche K; Jensen JB
    BJU Int; 2016 Jul; 118(1):102-11. PubMed ID: 26216234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.